Just coming back to this again, I think there is of course a truth in this which everyone knows but MS and co have always 'conveniently' overlooked. But with that special BPS-brigade twist:
- PACE almost certainly did include participants who did not have ME, but whose outcomes where nonetheless gathered with no true distinction of whether they had ME or not.
- The (mis)reported outcomes of PACE have been used and abused to bolster the use of CBT-a-la-PACE and GET as treatments for ME, even though PACE did not uniquely trial ME.
- Muddling up illnesses within a trial, and then presenting treatments that were arrived at on a whole-cohort basis, as being suitable for a poorly identified trial subset (that itself was likely unrepresentative of the population in general), seems itself to be dreadfully amateur.
MS et al have never ever tried to set the record straight for PwME, even though they would have been best placed to do so, and even though they have (sort of) admitted the treatments they trialled were not uniquely for ME. If there is ever an inquest, this to me is a key point that should not be overlooked, when they make their stock announcement that all they ever want is the best for patients.
So yes, PACE did not really target ME, yet everything in its literature, from the bottom up, claimed it did; conflation to suit the authors, DWP, disability insurers, NHS funding, etc.